Sepsis Diagnostics Market Analysis and Forecast to 2031: By Product (Instruments, Blood Culture Media, Assay Kits and Reagents), Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry), Pathogen (Bacterial Sepsis, Fungal Sepsis), Te

Sepsis Diagnostics Market Analysis and Forecast to 2031: By Product (Instruments, Blood Culture Media, Assay Kits and Reagents), Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry), Pathogen (Bacterial Sepsis, Fungal Sepsis), Testing Type (Laboratory Testing, PoC Testing), End-use (Hospitals and Specialty Clinics, Pathology & Reference Laboratories, Research Laboratories & Academic Institutes) and Region

The global sepsis diagnostics market was valued at USD 503.4 million in 2021 and it is anticipated to grow up to USD 1181.5 million by 2031, at a CAGR of 8.9% during the forecast period.


Sepsis is a potentially fatal illness that arises when the body's immune system attacks its own tissues in reaction to an infection. When the infection-fighting processes turn on the body, they cause organs to function poorly and abnormally. Septic shock can develop from sepsis. This is a sudden reduction in blood pressure that can cause serious organ damage and even death. Treatment with antibiotics and intravenous fluids as soon as possible enhances the chances of survival.

Global Sepsis Diagnostics Market Scope and Report Structure

Market Trends and Drivers

Rising incidence of hospital-acquired infections will augment the market growth during the forecast period. Hospital-acquired infections (HAIs), also known as nosocomial infections, are a major cause of morbidity and mortality worldwide. The most common hospital-acquired infections (HAIs) are urinary tract infections, pneumonia, and sepsis. HAIs can lead to sepsis in immunocompromised patients, geriatric patients, and patients suffering from chronic illnesses. In the U.S., the incidence of sepsis among hospitalized patients is rising by 8.7% per year. It is estimated that there are more than 1,000,000 incidences of sepsis among hospitalized patients annually in the nation {Source: CDC, 2018). With the rapid increase in HAIs worldwide, the demand for sepsis diagnostic products is also expected to rise in the coming years.

Market Restraints and Challenges

High cost of automated diagnostic devices may hamper the industry growth. The cost of molecular diagnostic tests is between USD 300 and USD 3,000, which is very high compared to the cost of blood culture tests, priced as low as ~USD 28–35. Companies focus on developing automated diagnostic devices based on advanced technologies, such as molecular diagnostics, on detecting sepsis but due to limited budgets, government hospitals (especially in emerging nations) and academic research laboratories cannot afford such systems. Further, becoming the major factor for the hindrance of the growth of sepsis diagnostics market.

Global Sepsis Diagnostics Market Segmental Overview

The report analyses the global sepsis diagnostics market based on product, technology, pathogen, testing type, end use, and region.

Global Sepsis Diagnostics Market by Product

Based on product, it is segmented into instruments, blood culture media, and assay kits and reagents. The blood culture media segment accounted for the largest share of market during the forecast period. This share can be attributed to the growing utilization of blood culture media by hospitals & pathology laboratories for the diagnosis of sepsis coupled with an increase in the availability of blood culture media in the market. Additionally, blood culture is considered to be the most convenient and cost-effective mode of testing by clinicians. Hence, aforementioned aspect is expected to fuel the segmental growth.

Global Sepsis Diagnostics Market by Technology

Based on technology, it is segmented into microbiology, molecular diagnostics, immunoassays, and flow cytometry. The microbiology technology segment dominated the global market and accounted for the largest share in 2021. This can be attributed to the fact that microbiology technology allows accurate detection and identification of microorganisms for sepsis diagnosis through the application of culture media tests. In addition, new strategic initiatives by key players are driving the segment growth. For instance, in April 2019, BD launched its new BD BACTEC platelet quality control media, which helps identify and decrease the incidence of sepsis in patients receiving platelet transfusion.

Global Sepsis Diagnostics Market by Pathogen

Based on pathogen, it is segmented into bacterial sepsis, fungal sepsis and others. The bacterial sepsis segment held the largest revenue share in 2021 and is anticipated to maintain its lead over the forecast period owing to the rise in cases of bacterial sepsis, the higher occurrence of hospital-transmitted infections, and the rising number of surgical procedures conducted. According to the study published by SAGE Journals in January 2019, bacterial sepsis is the most common type, with 62.2% of patients infected with gram-negative bacteria and 46.8% with gram-positive bacteria.

Global Sepsis Diagnostics Market by Testing Type

Based on testing type, it is segmented into laboratory testing, and PoC testing. The laboratory testing type segment dominated the market in 2021 with a share of more than 85.00%. This is mainly due to the fact that lab testing has greater accuracy in comparison to POC testing while diagnosing sepsis. Clinical laboratory testing provides an in-depth analysis of the pathogen and its drug resistance profile. In addition, routine testing of lactate levels, which are nonspecific, however, a useful marker of sepsis, is effectively performed in laboratory settings.

Global Sepsis Diagnostics Market by End-use

Based on end-use, it is segmented into Laboratory Testing, and PoC Testing. The hospitals and specialty clinics accounted for the largest share of the sepsis diagnostics industry. The larger share of this segment can be attributed to the high prevalence of sepsis coupled with a large number of fatalities caused by the illness, increasing number of patients hospitalized with sepsis, and in-house hospital laboratories perform a large number of blood culture tests to identify the blood stream infections (BSIs caused by bacteria, fungi/yeast, or viruses) thus, fueling the market growth.

Geographical Analysis of Global Sepsis Diagnostics Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America is the largest regional market in sepsis diagnostics market North America is a well-established market for medical devices. The presence of a highly developed healthcare system, high adoption of innovative sepsis diagnostic technologies among medical professionals, reigning number of surgical procedures, increasing incidence of healthcare-associated infections (HAIs) and technological advancements in the field of sepsis diagnostics are the major factors driving the market growth in North America.

Major Players in the Global Sepsis Diagnostics Market COVID-19 Impact

The COVID-19 pandemic had a moderately positive effect on the sales of diagnostics products for sepsis. The global spread of covid-19 and the emerging cases of sepsis among covid-19 patients are likely to increase the demand for rapid diagnosis, accelerating the utilization of instruments, reagents, & assay kits for detection of sepsis. Lockdowns resulting from the pandemic caused people to delay undergoing health checkups, affecting the number of tests performed and reagent sales. The current COVID-19 pandemic has highlighted the risk faced by older adults, who are more susceptible to complications, including acute respiratory distress syndrome, usually due to pneumonia, which increases the risk of developing sepsis. Thus, increasing the need for early diagnosis of sepsis among patients with covid-19 infections.

Recent Developments

• In January 2022, At the 2022 edition of MEDLAB Middle East, Abbott showcased its portfolio of life-changing diagnostic tools and medical devices for point-of-care testing that help manage patients with COVID-19, diabetes cardiovascular disease and their comorbidities.
• In June 2021, bioMérieux signed an agreement with Specific Diagnostics to distribute a specific reveal rapid AST system in Europe.
• In December 2021, SeptiCyte RAPID, a product by Immunoexpress, was granted approval by the United States Food and Drug Administration (FDA).
• In October 2021, Prenosis Inc. extended its existing deal with Roche Diagnostics to increase the speed of clinical diagnosis of sepsis. Prenosis Inc. is a precision diagnostics firm that applies Artificial Intelligence (AI) to improve clinical diagnosis.
• In September 2020, Roche Diagnostics collaborated with Inotrem to develop the sTREM-1 test, a diagnostic solution for sepsis.

Frequently Asked Questions

Q1. How big is the sepsis diagnostics market market?Ans. The global sepsis diagnostics market size was USD 503.4 million in 2021 and is anticipated to reach USD 1181.5 million in 2031, growing at a rate of 8.9% from 2022 to 2031.
Q2. What is the sepsis diagnostics market growth rate?Ans. The growth rate of the sepsis diagnostics market is 8.9%.
Q3. Which region holds a major market share for the sepsis diagnostics market?Ans. North America holds a major market share of the sepsis diagnostics market in 2021.
Q4. Which segment accounted for the largest sepsis diagnostics market share?Ans. By end user, the healthcare segment accounted for the largest sepsis diagnostics market share.
Q5. Who are the key players in the sepsis diagnostics market?Ans. The global sepsis diagnostics market report includes players such as
Q6. What are the factors driving the sepsis diagnostics market growth?Ans. The major factors driving the growth of the market are the rising incidence of HAI’s across the globe.
Q7. What are the key growth strategies of sepsis diagnostics market players?Ans. The key growth strategies of sepsis diagnostics market players are product launch and product approval.
Q8. Which regionwill provide more business opportunities for the sepsis diagnostics market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the sepsis diagnostics market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.